Jaka jest cena za Medigene AG (MDG1)

Cena za Medigene AG (MDG1) wynosi $0.14942078

Jaka jest kapitalizacja rynkowa dla Medigene AG (MDG1)

Kapitalizacja rynkowa dla Medigene AG (MDG1) wynosi $3.86M

Medigene AG (MDG1) Podziały Akcji

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Rok	Podział	Mnożnik	Skumulowany mnożnik
2024-08-29	1:2	x0.5	x0.125
2013-09-03	1:4	x0.25	x0.25

Rok

Podział

Mnożnik

Skumulowany mnożnik

2024-08-29

1:2

x0.5

x0.125

2013-09-03

1:4

x0.25

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj